4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-21-015788
Director sold 19,142 shares at $2.93 ($56,086)
- Director acquired 24,720 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
ANDREWS DEBORAH J · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-06-29 | Exercise or conversion : show line 1 in the form | +24,720 | $2.20 | $54,384 | 34,720 | D |
| 2021-06-29 | Sale : show line 2 in the form | −19,142 | $2.93 | $56,086 | 15,578 | D |
| Open-market sales · 19,142 sh · avg $2.93 · $56,086 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-06-29 | Exercise or conversion : show line 3 in the form Stock Option (right to buy) | −24,720 | 0 | D |
Loading xslF345X03/ownership.xml…